The Asheville project: Long-term clinical and economic outcomes of a community pharmacy diabetes care program

Journal of the American Pharmacists Association

Volumn 43, Issue 2, 2003, Pages 173-184

  Cranor, Carole W ^a   Bunting, Barry A ^b   Christensen, Dale B ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b Mission St Joseph's Health System   (United States)

Author keywords

Asheville Project; Diabetes; Health care costs; Health outcomes; Pharmaceutical care; Quality of life

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; COUNSELING; DIABETES MELLITUS; ECONOMICS; FEMALE; HUMAN; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT EDUCATION; PATIENT SATISFACTION; PHARMACIST; PHARMACY; QUESTIONNAIRE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; COMMUNITY PHARMACY SERVICES; COUNSELING; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT EDUCATION; PATIENT SATISFACTION; PHARMACISTS; QUESTIONNAIRES;

EID: 0037849900     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/108658003321480713     Document Type: Article

References (14)

1. Johnson JA. Self-efficacy theory as a framework for community pharmacy- based diabetes education programs. Diabetes Educ. 1996;22:237-41.
2. Norris SL, Lau J, Smith SJ, et al. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care. 2002;25:1159-71.
3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977-86.
4. U.S. Bureau of Health Professions. Report on Health Professional Accessibility. Washington, DC: Government Printing Office; 1996.
5. Cranor CW, Christensen DB. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:149-59.
6. Cranor CW, Christensen DB. The Asheville Project: factors associated with outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:160-72.
7. American Diabetes Association. American Diabetes Association: clinical practice recommendations 2002. Diabetes Care. 2002;25:1-139.
8. American Diabetes Association. Standards of medical care for patients with diabetes mellitus (position statement). Diabetes Care. 2002;25:S33-49.
9. Rothman KJ, Greenland S. Modern Epidemiology. Philadelphia, Pa: Lippincott-Raven; 1998:406.
10. American Diabetes Association. Implications of the Diabetes Control and Complications Trial. Diabetes Care. 2002;25:S25-7.
11. Hirsch IB, Goldberg HI, Ellsworth A, et al. A multifaceted intervention in support of diabetes treatment guidelines: a cont trial. Diabetes Res Clin Pract. 2002;58:27-36.
12. Nau DP, Ponte CD. Effects of a community pharmacist-based diabetes patient-management program on intermediate clinical outcome measures. J Manage Care Pharm. 2002;8(1):48-53.
13. Wagner EH, Sandhu N, Newton KM, et al. Effect of improved glycemic control on health care costs and utilization. JAMA. 2001;285:182-9.
14. Irons BK, Lenz RJ, Anderson SL, et al. A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic. Pharmacotherapy. 2002;22:1294- 1300.